Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

J -Adrenergic blockers

Rarely, patients are refractory to epinephrine treatment [24], and require other potent vasopressors [1, 2, 18, 22]. In those patients who are refractory to epinephrine because they are taking a (J-adrenergic blocker, glucagon should be administered intravenously [5, 18]. [Pg.215]

All patients with cirrhosis and portal hypertension should be considered for endoscopic screening, and patients with large varices should receive primary prophylaxis with /J-adrenergic blockers. [Pg.256]

Endoscopic band ligation (EBL) should be considered in patients with contraindications or intolerance to /J-adrenergic blockers. [Pg.256]

J-Adrenergic blockers Increased metoprolol serum concentrations and bradycardia possible heart block... [Pg.1247]

J-Adrenergic blockers Fivefold increase in propranolol serum concentration bradycardia and hypotension with combined fluvoxamine and metoprolol... [Pg.1248]

FIGURE 2.16 Direct chromatographic resolution of four racemic P-adrenergic blockers (a) oxprenolol, (b) alprenolol, (c) metoprolol, and (d) propranolol. (From Badaloni, E. et ah, J. Chromatogr. B, 796, 45, 2003. With permission from Elsevier, Copyright (2003).)... [Pg.146]

J. R. Teerlink, B. M. Massie (1999). P-Adrenergic blocker mortality trials in congestive heart failure. Am. J. Cardiol. 84 94R. [Pg.302]

Bernadt MW, Silverstone T, Singleton W. b-Adrenergic blockers in phobic disorder. Br J Psychiatry 1980 137 452-457. [Pg.250]

Nickel JC, Sander S, Moon TD A meta-analysis of the vascular-related safety profile and efficacy of alpha-adrenergic blockers for symptoms related to benign prostatic hyperplasia. Int J Clin Pract 2008 62 1547. [PMID 18822025]... [Pg.220]

Moser M, Setaro J. Continued importance of diuretics and beta-adrenergic blockers in the management of hypertension. Med Clin North Am. 2004 88 167-187. [Pg.304]

Satwani S, Dec GW, Narnia J. Beta-adrenergic blockers in heart failure review of mechanisms of action and clinical outcomes. J Cardiovasc Pharmacol Ther. 2004 9 243-255. [Pg.346]

B. Baveja, S. K., Ranga Roa, K. V., and Padmalatha Devi, K. (1987), Zero-order release hydrophilic matrix tablets of P-adrenergic blockers, Int. J. Pharm., 40, 223-234. [Pg.1051]

Steinhert J, Pugh CR. Two patients with schizophrenic-like psychosis after treatment with beta-adrenergic blockers. BMJ 1979 1(6166) 790. [Pg.703]

Houston MC, Hodge R. Beta-adrenergic blocker withdrawal syndromes in h q er tension and other cardiovascular diseases. Am Heart J 1988 116 515-23. [Pg.311]

Marshall AJ, Baddeley H, Barritt DW, Davies JD, Lee RE, Low-Beer TS, Read AE. Practolol peritonitis. A study of 16 cases and a survey of small bowel function in patients taking beta adrenergic blockers. Q J Med 1977 46(181) 135-49. [Pg.474]

Howard PJ, Lee MR. Beware beta-adrenergic blockers in patients with severe nrticaria Scott Med J 1988 33(5) 344-5. [Pg.477]

Shore JH, Fraunfelder FT, Meyer SM. Psychiatric side effects from topical ocular timolol, a beta-adrenergic blocker. J Chn Psychopharmacol 1987 7(4) 264-7. [Pg.1307]

Fischer, L. Muller, R. Ekberg, B. Mosbach, K. Direct enantioseparation of B-adrenergic blockers using a chiral stationary phase prepared by molecular imprinting. J. Am. Chem. Soc. 1991, 113, 9358-9360. [Pg.1745]

Sra JS, Vishnubhakta S, Murthy S, et al. Use of intravenous esmolol to predict efficacy of oral beta-adrenergic blocker therapy in patients with neurocardiogenic syncope. J Am Coll Cardiol 1992 19 402 08. [Pg.356]

Adrenergic blockers 4- Cardiac output t Renal vascular resistance (nonselective agents) T Renal vascular resistance ( /J -selective agents) Decrease in GFR and RBF Decrease in GFR and RBF No change in GFR and RBF... [Pg.809]

TV Olah, JD Gilbert, A Banish. Determination of the beta-adrenergic blocker timolol in plasma by liquid chromatography-atmospheric pressure chemical ionization mass spectrometry. J Pharm Biomed Anal 11 157, 1993. [Pg.193]

Atenolol (J-Adrenergic receptor Competitive blocker of p-Adrenergic... [Pg.327]

See other pages where J -Adrenergic blockers is mentioned: [Pg.966]    [Pg.59]    [Pg.59]    [Pg.124]    [Pg.4]    [Pg.582]    [Pg.966]    [Pg.59]    [Pg.59]    [Pg.124]    [Pg.4]    [Pg.582]    [Pg.732]    [Pg.113]    [Pg.387]    [Pg.20]    [Pg.176]    [Pg.89]    [Pg.136]    [Pg.159]    [Pg.184]    [Pg.186]    [Pg.199]    [Pg.203]    [Pg.225]    [Pg.285]    [Pg.286]    [Pg.301]    [Pg.309]    [Pg.330]    [Pg.504]    [Pg.539]   


SEARCH



Adrenergic blockers

J)-Adrenergic blockers adverse effects

J)-Adrenergic blockers and hypertension

JS-Blockers

© 2019 chempedia.info